Dirk Thye, CEO: Quince Therapeutics QNCX Buy · Filed 23/08/11

Trade details

Type: Insider buy
Amount: $110,880
Shares · price: 88,000 sh · $1.26 a share
Held after: 448,911 sh
Stock: Quince Therapeutics QNCX
Person: Dirk ThyeCEO
Trade date: 23/08/10
Filed: 23/08/11
Days to filing: 1 days

4 insiders bought this week

Insiders buying this week: 4 insiders
Holding change: +24.4%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/11~23/09/09

Dirk Thye's recent trades

Dirk ThyeCEO and Chief Medical Officer
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$53.9K
77,000 sh
$53.9K
Filed 24/09/03
Traded 24/08/30
Dirk ThyeCEO and Chief Medical Officer
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$53.5K
77,500 sh
$53.5K
Filed 24/09/03
Traded 24/08/29
Dirk ThyeCEO
BuyQuince Therapeutics
Buy
Quince Therapeutics
QNCX
$99.2K
80,000 sh
$99.2K
Filed 23/08/09
Traded 23/08/08